194 related articles for article (PubMed ID: 17525794)
21. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
22. Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations.
Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
Cell Oncol; 2009; 31(3):235-47. PubMed ID: 19478391
[TBL] [Abstract][Full Text] [Related]
23. Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.
Nagpal JK; Nair S; Chakravarty D; Rajhans R; Pothana S; Brann DW; Tekmal RR; Vadlamudi RK
Mol Cancer Res; 2008 May; 6(5):851-61. PubMed ID: 18505929
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.
Rayala SK; Hollander Pd; Balasenthil S; Molli PR; Bean AJ; Vadlamudi RK; Wang RA; Kumar R
J Biol Chem; 2006 Feb; 281(7):4395-403. PubMed ID: 16352611
[TBL] [Abstract][Full Text] [Related]
25. Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain.
Khan MM; Hadman M; De Sevilla LM; Mahesh VB; Buccafusco J; Hill WD; Brann DW
Neuroendocrinology; 2006; 84(5):317-29. PubMed ID: 17142998
[TBL] [Abstract][Full Text] [Related]
26. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
[TBL] [Abstract][Full Text] [Related]
27. Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
Vadlamudi RK; Manavathi B; Balasenthil S; Nair SS; Yang Z; Sahin AA; Kumar R
Cancer Res; 2005 Sep; 65(17):7724-32. PubMed ID: 16140940
[TBL] [Abstract][Full Text] [Related]
28. Extranuclear coactivator signaling confers insensitivity to tamoxifen.
Kumar R; Zhang H; Holm C; Vadlamudi RK; Landberg G; Rayala SK
Clin Cancer Res; 2009 Jun; 15(12):4123-30. PubMed ID: 19470742
[TBL] [Abstract][Full Text] [Related]
29. Signaling regulation of genomic and nongenomic functions of estrogen receptors.
Acconcia F; Kumar R
Cancer Lett; 2006 Jul; 238(1):1-14. PubMed ID: 16084012
[TBL] [Abstract][Full Text] [Related]
30. Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis.
Rayala SK; Mascarenhas J; Vadlamudi RK; Kumar R
Mol Cancer Ther; 2006 Feb; 5(2):230-7. PubMed ID: 16505095
[TBL] [Abstract][Full Text] [Related]
31. Regulation of rDNA transcription by proto-oncogene PELP1.
Gonugunta VK; Nair BC; Rajhans R; Sareddy GR; Nair SS; Vadlamudi RK
PLoS One; 2011; 6(6):e21095. PubMed ID: 21695158
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.
Nair BC; Nair SS; Chakravarty D; Challa R; Manavathi B; Yew PR; Kumar R; Tekmal RR; Vadlamudi RK
Cancer Res; 2010 Sep; 70(18):7166-75. PubMed ID: 20807815
[TBL] [Abstract][Full Text] [Related]
33. Cloning, expression, and localization of MNAR/PELP1 in rodent brain: colocalization in estrogen receptor-alpha- but not in gonadotropin-releasing hormone-positive neurons.
Khan MM; Hadman M; Wakade C; De Sevilla LM; Dhandapani KM; Mahesh VB; Vadlamudi RK; Brann DW
Endocrinology; 2005 Dec; 146(12):5215-27. PubMed ID: 16141397
[TBL] [Abstract][Full Text] [Related]
34. Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
Ohshiro K; Rayala SK; Kondo S; Gaur A; Vadlamudi RK; El-Naggar AK; Kumar R
Cancer Res; 2007 Sep; 67(17):8164-71. PubMed ID: 17804729
[TBL] [Abstract][Full Text] [Related]
35. MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation.
Kayahara M; Ohanian J; Ohanian V; Berry A; Vadlamudi R; Ray DW
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1047-55. PubMed ID: 18682536
[TBL] [Abstract][Full Text] [Related]
36. PELP1: a key mediator of oestrogen signalling and actions in the brain.
Thakkar R; Sareddy GR; Zhang Q; Wang R; Vadlamudi RK; Brann D
J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 28485080
[TBL] [Abstract][Full Text] [Related]
37. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).
Gururaj AE; Peng S; Vadlamudi RK; Kumar R
Mol Endocrinol; 2007 Aug; 21(8):1847-60. PubMed ID: 17505058
[TBL] [Abstract][Full Text] [Related]
38. PELP1--a novel estrogen receptor-interacting protein.
Brann DW; Zhang QG; Wang RM; Mahesh VB; Vadlamudi RK
Mol Cell Endocrinol; 2008 Aug; 290(1-2):2-7. PubMed ID: 18571832
[TBL] [Abstract][Full Text] [Related]
39. Characterization of MNAR expression.
Greger JG; Guo Y; Henderson R; Ross JF; Cheskis BJ
Steroids; 2006 Apr; 71(4):317-22. PubMed ID: 16297421
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
